• APEIRON Biologics Commences Clinical COVID-19 Trial with Inhaled APN01  10/12/2021
• APEIRON Biologics Announces Changes to Management and Supervisory Boards 6/2/2021
• APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-1... 4/2/2020
• APEIRON Starts Pilot Clinical Trial on it's Respiratory Drug to Treat COVID-19 Coronavirus... 2/26/2020
• APEIRON to Present Clinical Data on Two Immunotherapy Programs 5/31/2018
• APEIRON to Present at the Biotech Showcase™ Annual Conference 1/8/2018